Trip.com Group Ltd (TCOM) Stock Price Today
Aura AI Summary
Key Stats
- $28.76BMarket Cap
- -Volume
- Consumer CyclicalSector
- $78.9652W High
- $39.8452W Low
- -Typical Hold Time
- $21.37BEnterprise Value
- 0.42%Div Yield
- -Trading Activity
Track Trip.com Group Ltd (TCOM) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Trip.com Group Ltd has traded between a low of $39.84 and a high of $78.96, highlighting its annual price range. Buy and sell Trip.com Group Ltd shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Trip.com Group Ltd
Trip.com is the largest online travel agent in China and is positioned to benefit from the country's rising demand for higher-margin outbound travel as passport penetration is only 12% in China. The company generated about 78% of sales from accommodation reservations and transportation ticketing in 2020. The rest of revenue comes from package tours and corporate travel. Prior to the pandemic in 2019, the company generated 25% of revenue from international business, which is important to its margin expansion. Most of sales come from websites and mobile platforms, while the rest come from call centers. The competes in a crowded OTA industry in China, including Meituan, Alibaba-backed Fliggy, Toncheng, and Qunar. The company was founded in 1999 and listed on the Nasdaq in December 2003.
Most Recent News
American Airlines rejects merger, faces uncertain turnaround with weak financials and stiff competition.
American Airlines has rejected a merger proposal from United Airlines, leaving it to face a challenging turnaround amid a weak balance sheet and tough competition. While Delta and United have seen significant stock gains over the past decade, America...
Leifras wins contract to manage weekend club activities at 19 junior high schools in Chiba City.
Leifras Co., Ltd. secured a new contract in April 2026 to manage weekend community club activities at 19 public junior high schools in Chiba City, Japan. This marks Leifras' first contract in Chiba and aligns with Japan's national policy to shift sch...
Caris Life Sciences launches AI tool to personalize pancreatic cancer treatment, improving survival rates.
Caris Life Sciences introduced an AI-driven method called Caris AI Insights™ to optimize first-line treatment for pancreatic cancer, showing improved survival outcomes by tailoring therapy based on tumor biology. The AI model helps predict which pati...
People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.